Manufacture and Delivery of Dose Specific and Dose Banded Systemic Anti-Cancer Treatments
Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient.
The outsourced doses will be purchased in the form of both readymade dose banded products and patient specific doses.
sact, patient specific, dose banded, chemo, cytoxic, systemic